This study aimed to investigate the efficiency and standards in the superrovulatory response to products with different relationships FSH:LH. It Were used 43 female Boer goats breed. On a random day of the estrous cycle, the animals received half of an implant of progesterone (Crestar®). In the eleventh day, began stimulation to superovulation through the use of FSH fractionated in six decreasing doses administered every 12 hours and the animals were separated into two groups: group I (GI, n=22) received 200mg of FSH (Folltropin®) intramuscularly (i.m) on days D11 (62,5mg), D12 (35,0mg) and D13 (2,5mg), while the group II (GII, n=21) received 300UI FSH (Pluset®) intramuscularly on days D11 (75UI), D12 (50UI) and D13 (25UI). In 60 and 72h after onset of superovulation the implants were removed and applied two doses of 125µg de Cloprostenol (Ciosin®) by intravulvosubmucosal in all animals. Twelve, 24 and 36 hours after removal of the implant, the females were placed with four breeders to be covered. In D16, the implants were reinserted and 24 hours before collection of embryos the implants were withdrawl and administered 125µg de Cloprostenol in each animal intramuscularly. Embryo were collected on D21, selected and classified. The results obtained in this study showed no statistical difference between groups regarding the number of recovered structures, viable embryos, degenerate embryos and unfertilized structures. So, the different relationships FSH:LH evaluated did not affect embryos production and quality.
animal reproduction; gonadotropic hormones; superovulation; embryo transfer